每日使用甲状旁腺激素联合骨化三醇治疗绝经后骨质疏松症。 - Suppr

Suppr

超能文献

Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol.

作者信息

Neer M, Slovik D M, Daly M, Potts T, Nussbaum S R

机构信息

Massachusetts General Hospital, Department of Medicine, Boston.

出版信息

Osteoporos Int. 1993;3 Suppl 1:204-5. doi: 10.1007/BF01621907.

DOI:10.1007/BF01621907

PMID:8461561

Abstract

摘要

相似文献

Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol.

Osteoporos Int. 1993;3 Suppl 1:204-5. doi: 10.1007/BF01621907.

[Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].

Clin Calcium. 2007 Dec;17(12):1823-9.

[Therapy of osteoporosis using the ADFR schedule (especially with parathyroid hormone and etidronate)].

Internist (Berl). 1991 Feb;32(2):76-9.

Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.

J Clin Endocrinol Metab. 2001 Aug;86(8):3618-28. doi: 10.1210/jcem.86.8.7703.

A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.

J Clin Endocrinol Metab. 1997 Feb;82(2):620-8. doi: 10.1210/jcem.82.2.3762.

Combination and sequential therapy for osteoporosis.

N Engl J Med. 2005 Aug 11;353(6):624-5. doi: 10.1056/NEJMe058154.

Daily and cyclic parathyroid hormone in women receiving alendronate.

N Engl J Med. 2005 Aug 11;353(6):566-75. doi: 10.1056/NEJMoa050157.

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.

N Engl J Med. 2003 Sep 25;349(13):1207-15. doi: 10.1056/NEJMoa031975. Epub 2003 Sep 20.

PREOS NPS (Allelix/Nycomed).

Curr Opin Investig Drugs. 2005 Oct;6(10):1057-66.

ALX 111: ALX1-11, parathyroid hormone (1-84) - NPS Allelix, PREOS, PTH, recombinant human parathyroid hormone, rhPTH (1-84).

Drugs R D. 2003;4(4):231-5. doi: 10.2165/00126839-200304040-00003.

引用本文的文献

The Effect of Teriparatide on the Hip: A Literature Review.

Hip Pelvis. 2021 Jun;33(2):45-52. doi: 10.5371/hp.2021.33.2.45. Epub 2021 Jun 4.

Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats.

Drug Deliv Transl Res. 2017 Aug;7(4):482-496. doi: 10.1007/s13346-017-0407-2.

Parathyroid hormone and its receptor gene polymorphisms: implications in osteoporosis and in fracture healing.

Rheumatol Int. 2016 Jan;36(1):1-6. doi: 10.1007/s00296-015-3319-9. Epub 2015 Jul 21.

The use of intermittent human parathyroid hormone as a treatment for osteoporosis.

Curr Rheumatol Rep. 2004 Feb;6(1):49-58. doi: 10.1007/s11926-004-0083-3.

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.

J Clin Invest. 1998 Oct 15;102(8):1627-33. doi: 10.1172/JCI3914.

Parathyroid hormone in the treatment of involutional osteoporosis: back to the future.

Osteoporos Int. 1997;7 Suppl 3:S163-8. doi: 10.1007/BF03194365.

Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH-(1-31)NH2 (Ostabolin).

Calcif Tissue Int. 1996 Feb;58(2):81-7. doi: 10.1007/BF02529728.

本文引用的文献

Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration.

Endocrinology. 1982 Feb;110(2):506-12. doi: 10.1210/endo-110-2-506.

Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.

Br Med J. 1980 Jun 7;280(6228):1340-4. doi: 10.1136/bmj.280.6228.1340.

Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds.

Endocrinology. 1983 Mar;112(3):1000-6. doi: 10.1210/endo-112-3-1000.

Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone.

Metab Bone Dis Relat Res. 1984;5(4):177-81. doi: 10.1016/0221-8747(84)90026-2.

Increase of whole-body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone.

Clin Sci (Lond). 1982 Apr;62(4):389-96. doi: 10.1042/cs0620389.

Parathyroid hormone and experimental osteosclerosis.

Lancet. 1970 Jun 27;1(7661):1363-6. doi: 10.1016/s0140-6736(70)91271-7.

Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.

J Bone Miner Res. 1986 Aug;1(4):377-81. doi: 10.1002/jbmr.5650010411.

Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients.

Bone Miner. 1990 May;9(2):137-52. doi: 10.1016/0169-6009(90)90080-y.

The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84).

Endocrinology. 1991 Jul;129(1):421-8. doi: 10.1210/endo-129-1-421.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验